☆ 4.7 Article

PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Effi cacy of a Small-Molecule Inhibitor of Kras G12D in Immunocompetent Models of Pancreatic Cancer

Samantha B. Kemp et al.

Summary: This study evaluated the efficacy of a small-molecule KRASG12D inhibitor, MRTX1133, in PDAC models with an intact immune system. The results showed that MRTX1133 can induce deep tumor regressions and alter the tumor microenvironment, demonstrating its potential as a novel therapy for PDAC patients. Further clinical testing is warranted.

CANCER DISCOVERY (2023)

Add to Collection

Article Oncology

Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes

Do Young Hyeon et al.

Summary: We conducted a proteogenomic analysis of PDAC and found signaling pathways associated with somatic mutations in significantly mutated genes. We also identified potential prognostic biomarkers correlated with patient survival. Integrated clustering of mRNA, protein, and phosphorylation data revealed six PDAC subtypes.

NATURE CANCER (2023)

Add to Collection

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Review Oncology

Prostaglandin Pathways: Opportunities for Cancer Prevention and

Qiushi Wang et al.

CANCER RESEARCH (2022)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Treatment of Type 1 Diabetes by Microbiome Maintenance

Warren Strober

GASTROENTEROLOGY (2022)

Add to Collection

Article Genetics & Heredity

A Prognostic Survival Model of Pancreatic Adenocarcinoma Based on Metabolism-Related Gene Expression

Lin-ying Xie et al.

Summary: This study analyzed RNA matrices of PAAD patients and identified genes related to PAAD cell metabolism regulation. A metabolic risk score was created using LASSO Cox regression analysis. The proposed scoring framework showed good predictive performance and improved the accuracy of survival prediction in PAAD patients.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Medicine, General & Internal

Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer

J. H. Strickler et al.

Summary: This study evaluated the safety and efficacy of sotorasib in patients with KRAS p.G12C-mutated pancreatic cancer who had previously received treatment. The results showed that sotorasib demonstrated anticancer activity and had an acceptable safety profile in these patients.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Biology

Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context

Samuel A. Kerk et al.

Summary: Mitochondrial glutamate-oxaloacetate transaminase 2 (GOT2) is a key component of glutamine metabolism in pancreatic ductal adenocarcinoma (PDA). Loss of GOT2 disrupts redox homeostasis and halts proliferation of PDA cells in vitro, but has no effect on tumor growth in vivo due to metabolic plasticity of PDA cells.

ELIFE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

Jill Hallin et al.

Summary: This study evaluated the mechanism and anti-tumor efficacy of MRTX1133, a non-covalent KRAS(G12D) inhibitor. Results showed that MRTX1133 had a high-affinity interaction with KRAS(G12D) and inhibited its activation, leading to tumor regression. Co-targeting additional pathways enhanced the anti-tumor activity.

NATURE MEDICINE (2022)

Add to Collection

Article Genetics & Heredity

Classification and Prognosis Analysis of Pancreatic Cancer Based on DNA Methylation Profile and Clinical Information

Xin Li et al.

Summary: This study identified differential methylated genes and cancer driver genes between two subtypes of Pancreatic adenocarcinoma (PAAD) through analysis of DNA methylation data and transcriptome data, and constructed a prognostic prediction model based on specific methylated genes. The findings shed new light on the heterogeneity of pancreatic tumors from an epigenetic perspective, offering new strategies and targets for personalized treatment plan evaluation and precision medicine for patients with PAAD.

GENES (2022)

Add to Collection

Article Oncology

Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155

Sinae Kim et al.

Summary: The study reveals the crucial role of miR-155 in the connection between cancer and prostaglandin metabolism. It shows that miR-155 can reprogram prostaglandin metabolism by regulating the expression of specific enzymes and is positively correlated with the PGE2/PGD2 ratio.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Review Oncology

Targeting hypoxic tumor microenvironment in pancreatic cancer

Jinxin Tao et al.

Summary: Pancreatic cancer, characterized by late diagnosis, early metastasis, and poor prognosis, exhibits high lethality globally. The hypoxic microenvironment in pancreatic cancer has extensive effects on biological behaviors and malignant phenotypes, leading to aggressive progression and therapeutic resistance. Innovative therapies targeting the tumor hypoxic microenvironment show great potential in overcoming treatment resistance and enhancing antitumor efficacy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Dingzhi Wang et al.

Summary: The cyclooxygenase-2-prostaglandin E2 pathway plays an important role in the development of gastrointestinal cancer, promoting tumor growth and affecting host defenses. Overcoming tumor immune evasion is a major challenge in cancer immunotherapy.

GASTROENTEROLOGY (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications

Hai-feng Hu et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with high mortality rate due to lack of early diagnosis measures and strong resistance to chemotherapy. Research focus is on studying the functions of key driver genes and their clinical implications for further application.

ACTA PHARMACOLOGICA SINICA (2021)

Add to Collection

Review Gastroenterology & Hepatology

Harnessing metabolic dependencies in pancreatic cancers

Joel Encarnacion-Rosado et al.

Summary: PDAC is a highly aggressive cancer with unique tumor microenvironment, which can reprogram metabolism to adapt to the harsh conditions and develop therapeutic resistance. PDAC cells survive in the hostile environment by using non-canonical metabolic pathways and scavenging pathways.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Genetics & Heredity

Aberrantly DNA Methylated-Differentially Expressed Genes in Pancreatic Cancer Through an Integrated Bioinformatics Approach

Haifeng Sun et al.

Summary: This study identified 31 methylated-differentially expressed genes (MeDEGs) in pancreatic cancer, including 5 hypermethylated/downregulated genes correlated with poor patient survival. These genes were enriched in cancer-related pathways and interacted with each other, suggesting a significant role in pancreatic cancer development and prognosis.

FRONTIERS IN GENETICS (2021)

Add to Collection

Review Cell Biology

The biological underpinnings of therapeutic resistance in pancreatic cancer

Gregory L. Beatty et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer-related mortality in the United States, with a low survival rate of 10% over 5 years. The disease demonstrates remarkable adaptability and resistance to therapeutic intervention, contributing to its poor prognosis. Recent advances in understanding the biological underpinnings of PDAC have revealed potential vulnerabilities that can be targeted for treatment.

GENES & DEVELOPMENT (2021)

Add to Collection

Article Health Care Sciences & Services

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Andras Lanczky et al.

Summary: The web-based tool introduced in this study enables univariate and multivariate Cox proportional hazards survival analysis using data from various genomic studies, filling a significant gap in the field where no commonly used spreadsheet software or web server is available for this purpose.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Add to Collection

Review Oncology

Therapeutic targeting of the hypoxic tumour microenvironment

Dean C. Singleton et al.

Summary: The article discusses the relationship between two different tumor microenvironment research fields: physicochemical gradients and cellular interactions, with a focus on translational therapeutic opportunities. Hypoxia is a common feature of tumors, influencing various cancer characteristics and responses to anticancer therapies.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

Balazs Gyorffy

Summary: This study presents a ranking of all survival-related genes in chemotherapy treated basal and estrogen positive/HER2 negative breast cancer, providing a reference for future biomarker research. By analyzing hazard rates and p values of genes, the most promising prognostic genes can be identified, helping to focus research on candidates with the most clinical significance.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Add to Collection

Article Genetics & Heredity

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Michelle Chan-Seng-Yue et al.

NATURE GENETICS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model

Tong Wang et al.

ONCOGENE (2020)

Add to Collection

Review Biology

Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity

Federica Finetti et al.

BIOLOGY-BASEL (2020)

Add to Collection

Article Allergy

T cell-intrinsic prostaglandin E2-EP2/EP4 signaling is critical in pathogenic TH17 cell-driven inflammation

Jinju Lee et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Genetics & Heredity

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

Francesca Finotello et al.

GENOME MEDICINE (2019)

Add to Collection

Article Genetics & Heredity

GENT2: an updated gene expression database for normal and tumor tissues

Seung-Jin Park et al.

BMC MEDICAL GENOMICS (2019)

Add to Collection

Review Physiology

Epithelial-Stromal Interactions in Pancreatic Cancer

Yaqing Zhang et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)

Add to Collection

Article Oncology

Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis

Alessandro Carrer et al.

CANCER DISCOVERY (2019)

Add to Collection

Review Physiology

Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

Divya Murthy et al.

FRONTIERS IN PHYSIOLOGY (2018)

Add to Collection

Review Oncology

Metabolic Dependencies in Pancreatic Cancer

Ali Vaziri-Gohar et al.

FRONTIERS IN ONCOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Racial disparity in metabolic regulation of cancer

Kuldeep S. Attri et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2017)

Add to Collection

Article Oncology

Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk

Yong Cui et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

Add to Collection

Article Genetics & Heredity

Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis

Oliver G. McDonald et al.

NATURE GENETICS (2017)

Add to Collection

Review Cell Biology

Metabolic Interactions in the Tumor Microenvironment

Costas A. Lyssiotis et al.

TRENDS IN CELL BIOLOGY (2017)

Add to Collection

Article Biotechnology & Applied Microbiology

xCell: digitally portraying the tissue cellular heterogeneity landscape

Dvir Aran et al.

GENOME BIOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Willy Hugo et al.

CELL (2016)

Add to Collection

Review Cell Biology

The Emerging Hallmarks of Cancer Metabolism

Natalya N. Pavlova et al.

CELL METABOLISM (2016)

Add to Collection

Article Multidisciplinary Sciences

Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

Cristovao M. Sousa et al.

NATURE (2016)

Add to Collection

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Add to Collection

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Add to Collection

Review Oncology

Metabolic control of epigenetics in cancer

Adam Kinnaird et al.

NATURE REVIEWS CANCER (2016)

Add to Collection

Article Multidisciplinary Sciences

Whole genomes redefine the mutational landscape of pancreatic cancer

Nicola Waddell et al.

NATURE (2015)

Add to Collection

Article Multidisciplinary Sciences

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Eliezer M. Van Allen et al.

SCIENCE (2015)

Add to Collection

Article Oncology

Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer

Ines Cebola et al.

CLINICAL EPIGENETICS (2015)

Add to Collection

Article Multidisciplinary Sciences

Human Papillomavirus Infection Correlates with Inflammatory Stat3 Signaling Activity and IL-17 Level in Patients with Colorectal Cancer

Yi Xin Li et al.

PLOS ONE (2015)

Add to Collection

Review Oncology

Oncogenic KRAS signalling in pancreatic cancer

S. Eser et al.

BRITISH JOURNAL OF CANCER (2014)

Add to Collection

Article Oncology

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Lola Rahib et al.

CANCER RESEARCH (2014)

Add to Collection

Article Cell Biology

Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation

Joyce V. Lee et al.

CELL METABOLISM (2014)

Add to Collection

Article Oncology

Hypoxia-inducible factor-2 is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer

Xiang Xue et al.

CARCINOGENESIS (2013)

Add to Collection

Review Gastroenterology & Hepatology

Mucins in pancreatic cancer and its microenvironment

Sukhwinder Kaur et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)

Add to Collection

Article Multidisciplinary Sciences

Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma

Fabienne Guillaumond et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

Add to Collection

Review Immunology

Regulation of Immune Responses by Prostaglandin E-2

Pawel Kalinski

JOURNAL OF IMMUNOLOGY (2012)

Add to Collection

Editorial Material Oncology

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Ethan Cerami et al.

CANCER DISCOVERY (2012)

Add to Collection

Review Chemistry, Multidisciplinary

Prostanoid Receptors

Takako Hirata et al.

CHEMICAL REVIEWS (2011)

Add to Collection

Article Gastroenterology & Hepatology

Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis

Angel Lanas et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)

Add to Collection

Article Medicine, General & Internal

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

Sven Trelle et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Add to Collection

Article Oncology

Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis

James J. Lee et al.

CARCINOGENESIS (2010)

Add to Collection

Review Pathology

Pancreatic cancer

Anirban Maitra et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)

Add to Collection

Review Oncology

Mucins in cancer: Protection and control of the cell surface

MA Hollingsworth et al.

NATURE REVIEWS CANCER (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.